MANE

Conviction 38HealthcareScan · Thu, Sep 24, 2026

Veradermics, Inc (MANE) closed at $115.81 (+0.03%) on Sep 24, 2026. Price is above its 50-day. RSI(14) 63, -10.7% from its 52-week high, +206.8% year to date. Sector: Healthcare · Biotechnology.

MANE$115.81+0.03%

ResistanceSupportVol 14Insider sell

Vol MA14 885.12K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Veradermics, IncBiotechnologywww.veradermics.com ↗

Price115.81

Change+0.03%

Gap-0.05%

Rel volume1.71×

Avg volume764.89K

Avg $ vol81.49M

SMA 20103.85

SMA 50106.47

SMA 200—

Price vs 50+8.77%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 99.70

RSI (14)63

MACD hist2.14

MACD crossbull · 9d

Stoch %K / %D75 / 79

ADX (14)22

+DI / −DI26 / 12

RSI divergence—

MACD divergence—

ATR %5.31%

ADR %5.11%

52w high129.74

52w low37.03

From 52w high-10.74%

Above 52w low+212.75%

New 52w highNo

SqueezeOff

Bollinger width25.63%

%B0.95

Donchian pos76.71%

Donchian high122.00

Donchian low95.42

AVWAP (52w high)108.95

vs AVWAP high+6.30%

AVWAP (52w low)94.58

vs AVWAP low+22.45%

OBV trendUp

Chaikin MF (20)0.06

Today vs 20d1.71×

Avg vol (14d)885.12K

Avg vol (20d)764.89K

Avg $ vol (20d)81.49M

Market cap4.84B

RS Rating—

RS 3m (vs SPY)-7.47%

RS 6m (vs SPY)+59.83%

RS line new highNo

Trend template—

Technical rank93.8

1 week+6.56%

1 month+13.15%

3 months-2.98%

6 months+76.65%

1 year—

YTD+206.78%

P/E-69.13

P/B5.95

P/S—

P/FCF-67.55

EPS-111.91

Div yield—

ROE-8.60%

ROA-8.48%

Debt/Eq—

Current70.53

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-164.25%

Price target169.20

Target upside46.10%

Analyst ratingBuy

Institutional81.20%

Ent. value4.52B

Revenue—

Net income-23.5M

Gross profit—

Free cash flow-71.63M

IndustryBiotechnology

ExchangeNYSE

Shares out41.78M

Employees21

ListedWed, Feb 4, 2026

Free float19.62M

Float %52.5%

Short interest4.03M

Days to cover6.6d

Short volume59.1%

Squeeze score88 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.58 vs −$0.58

Last surprise0.0% beat

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank93.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance119.70

Support93.79

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MANE

All disclosures →

No recent disclosed trades by Congress in MANE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MANE · open-market 4 sells

Insider	Side	Shares	Value	Traded	Filed
MONTANOVA CAPITAL, LLC Director · Common stock, par value $0.00001 per share · 2026-08-20	Exercise	151K	—	2026-08-20	2026-08-21
MONTANOVA CAPITAL, LLC Director · Pre-Funded Warrants · 2026-08-20	Exercise	149K	—	2026-08-20	2026-08-21
MONTANOVA CAPITAL, LLC Director · Pre-Funded Warrants · 2026-08-20	Exercise	151K	—	2026-08-20	2026-08-21
MONTANOVA CAPITAL, LLC Director · Common stock, par value $0.00001 per share · 2026-08-20	Exercise	149K	—	2026-08-20	2026-08-21
MONTANOVA CAPITAL, LLC Director · Common stock, par value $0.00001 per share · 2026-08-19	Sell	690.6K	$74M	2026-08-19	2026-08-21
MONTANOVA CAPITAL, LLC Director · Common stock, par value $0.00001 per share · 2026-08-19	Sell	59.4K	$6.4M	2026-08-19	2026-08-21
Durso Timothy August Chief Technical Officer · Common Stock · 2026-08-17	Sell	161	$18K	2026-08-17	2026-08-18
Durso Timothy August Chief Technical Officer · Stock Option (Right to Buy) · 2026-08-17	Exercise	3.45K	—	2026-08-17	2026-08-18
Waldman Reid Alexander Chief Executive Officer · Common Stock · 2026-08-17	Exercise	3.45K	$42K	2026-08-17	2026-08-18
Waldman Reid Alexander Chief Executive Officer · Common Stock · 2026-08-17	Sell	11.53K	$1.2M	2026-08-17	2026-08-18

SEC filings

EDGAR filings in MANE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.